An Innovative Surfactant Delivery Solution to Treat NRDS
BLEScath™ Intratracheal catheter for less invasive administration of pulmonary surfactant NRDS is a challenge mitigated by integrated scientific solutions. LONDON,…
Pharmaceuticals, Biotechnology and Life Sciences
BLEScath™ Intratracheal catheter for less invasive administration of pulmonary surfactant NRDS is a challenge mitigated by integrated scientific solutions. LONDON,…
Following recent milestone, Lowell Farms enters the year as the largest combined seller of packaged flower and all-flower pre-rolls in California…
CARLSBAD, Calif., May 10, 2022 (GLOBE NEWSWIRE) — Palisade Bio (Nasdaq: PALI), a clinical-stage biopharmaceutical company advancing therapies for acute and…
Novel approach to addressing pigment loss disorder affecting an estimated 45 million individuals worldwide Vitiligo repigmentation in CLINUVEL’s CUV102 study…
Company announcement – No. 16/ 2022 Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy…
SAN DIEGO, May 09, 2022 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a biopharmaceutical company developing and commercializing specialty…
Data from COVID-19 Phase II study and norovirus Phase IB study are expected in 2022 Ended the 1st Quarter with…
DEVON, Pa., May 09, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid…
REDWOOD CITY, Calif., May 09, 2022 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to…
– Cash, cash equivalents and marketable securities totaled $192.1 million as of March 31, 2022, with projected cash runway into…